India’s drug pricing regulator has increased the ceiling prices of two critical cancer medicines, cisplatin and carboplatin, by 50% to address growing shortages across the country. The National Pharmaceutical Pricing Authority (NPPA) approved the one-time revision after rising raw material costs and supply disruptions affected the availability of these essential oncology Continue Reading
